Limited time75% off all plans
Get the app

Pharmacokinetic interaction mechanisms

On this page

Absorption Interactions - First-Pass Fumbles

  • Altered Gut Lumen Chemistry:

    • Chelation: Drugs bind in the gut, preventing absorption.
      • Example: Tetracyclines or fluoroquinolones + divalent cations (Ca²⁺, Mg²⁺, Fe²⁺) in antacids or dairy.
    • Altered pH: Changed stomach acidity impairs absorption of pH-dependent drugs.
      • Example: ↓ absorption of ketoconazole (needs acid) with proton pump inhibitors (PPIs).
  • Altered Gut Motility:

    • ↑ Motility: Less time for absorption (e.g., metoclopramide ↓ digoxin absorption).
    • ↓ Motility: More time for absorption (e.g., anticholinergics ↑ digoxin absorption).
  • Gut Wall Metabolism (First-Pass Fumbles):

    • Inhibition of enzymes in the gut wall (e.g., CYP3A4) increases bioavailability.

    ⭐ Grapefruit juice is a potent inhibitor of intestinal CYP3A4, significantly increasing levels of drugs like statins and calcium channel blockers, risking toxicity.

Grapefruit juice interaction with felodipine and CYP3A4

Distribution Interactions - Protein Binding Battles

  • Mechanism: A highly protein-bound drug is displaced from plasma proteins (e.g., albumin) by another drug. This ↑ the free (active) concentration of the displaced drug.
  • Equation: $Drug_{bound} ightleftharpoons Drug_{free} + Protein$
  • High-Risk Drugs: Those with >90% protein binding and a narrow therapeutic index.
    • Examples: Warfarin, Phenytoin, Methotrexate, Sulfonylureas.
  • Classic Interaction: Sulfonamides or Aspirin displace Warfarin, leading to ↑ free Warfarin and ↑ bleeding risk.

Reversible drug binding to albumin and retention

High-Yield Fact: The increase in free drug concentration is often transient. The newly freed drug is also more available for metabolism and excretion, which can lead to a new, lower total drug concentration steady-state over time.

Metabolism Interactions - CYP450 Power Plays

Cytochrome P450 (CYP450) enzymes are a major source of pharmacokinetic drug interactions. Modulating their activity can drastically alter drug concentrations, leading to toxicity or therapeutic failure.

Enzyme Inhibition Mechanisms

CYP450 Inducers (↓ Drug Levels)CYP450 Inhibitors (↑ Drug Levels)
Effect: Accelerate metabolism, ↓ substrate drug levels, potentially causing therapeutic failure.Effect: Slow metabolism, ↑ substrate drug levels, potentially causing toxicity.
Examples:Examples:
* Rifampin* Macrolides (e.g., Erythromycin)
* Phenobarbital* Azole antifungals (e.g., Ketoconazole)
* Carbamazepine* Grapefruit juice
* St. John's Wort* Protease Inhibitors (e.g., Ritonavir)
📌 Mnemonic: CRAP GPS (Carbamazepine, Rifampin, Alcohol (chronic), Phenytoin, Griseofulvin, Phenobarbital, Sulfonylureas)📌 Mnemonic: SICKFACES.COM (Sodium valproate, Isoniazid, Cimetidine, Ketoconazole, Fluconazole, Alcohol (acute), Chloramphenicol, Erythromycin, Sulfonamides, Ciprofloxacin, Omeprazole, Metronidazole)

Excretion Interactions - Kidney's Gatekeepers

  • Competition for Renal Transporters: Drugs can compete for active secretion into the renal tubules, primarily via Organic Anion Transporters (OATs) and Organic Cation Transporters (OCTs) in the proximal tubule.

    • Example: Probenecid ↓ renal clearance of Penicillin by inhibiting OAT-mediated secretion, thus ↑ its plasma concentration and half-life.
  • Alteration of Urine pH (Ion Trapping): Modifying urine pH changes the ionization state of weak acids/bases, affecting their reabsorption.

    • Weak Acids (e.g., Aspirin, Phenobarbital): Alkalinize urine with sodium bicarbonate ($HCO_3^−$) to ↑ excretion. $HA \rightleftharpoons H^+ + A^-$. Traps drug in its ionized, water-soluble form ($A^-$).
    • Weak Bases (e.g., Amphetamines): Acidify urine (e.g., with ammonium chloride, $NH_4Cl$) to ↑ excretion.

⭐ For salicylate (aspirin) toxicity, administer sodium bicarbonate to alkalinize the urine, which promotes ion trapping and enhances renal excretion.

High‑Yield Points - ⚡ Biggest Takeaways

  • CYP450 enzyme induction (e.g., rifampin) ↓ drug levels, while inhibition (e.g., grapefruit juice, azoles) ↑ toxicity.
  • P-glycoprotein (P-gp) inhibition ↑ drug absorption and bioavailability; induction does the opposite.
  • Altered absorption occurs via chelation (tetracyclines + iron) or gastric pH changes (antacids).
  • Displacement from plasma proteins (e.g., warfarin) ↑ free drug concentration and toxicity risk.
  • Altering urinary pH modifies the renal clearance of weak acids/bases (e.g., aspirin).

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE